A literature review of the epidemiology and treatment of acute gout (Q35177669)

6 August 2017

1 reference

title

A literature review of the epidemiology and treatment of acute gout (English)

1 reference

6 August 2017

1 reference

Karissa Y Kim

1

1 reference

6 August 2017

H Ralph Schumacher

2

1 reference

6 August 2017

Elke Hunsche

3

1 reference

6 August 2017

Albert I Wertheimer

4

1 reference

6 August 2017

Sheldon X Kong

5

1 reference

6 August 2017

1 June 2003

1 reference

6 August 2017

Clinical Therapeutics

1 reference

6 August 2017

25

1 reference

6 August 2017

1593-1617

1 reference

6 August 2017

6

1 reference

Prevention and management of gout

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Clinical manifestations of gout and their management.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

1 reference

7 January 2021

ABC of rheumatology. Gout, hyperuricaemia, and crystal arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout: diagnosis, pathogenesis, and clinical manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Investigation and management of gout in the young and the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout update: from lab to the clinic and back

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout: the last 50 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout and coronary heart disease: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout and hyperuricemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Clinical implications of insulin resistance syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Hyperlipidaemia in hyperuricaemia and gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout: new questions for an ancient disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Hyperuricemia and gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout, uric acid metabolism, and crystal-induced inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

1 reference

7 January 2021

Characteristics of gouty arthritis in the Guatemalan population

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Crystal-associated arthritis in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout in the elderly. Clinical presentation and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Female gout. Clinical spectrum and uric acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout in a New England town. A prevalence study in Sudbury, Massachusetts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Review of UK data on the rheumatic diseases--4. Gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout in black South Africans: a clinical and genetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

The epidemiology of hyperuricaemia and gout in Taiwan aborigines.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

The prevalence of gout in three English towns

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

The prevalence and prophylaxis of gout in England

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout is on the increase in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Chronic inflammatory rheumatic diseases in black Zimbabweans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout in patients attending the rheumatology unit of Lomé Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout in South African blacks

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Rheumatic disorders in Zimbabwe: a prospective analysis of patients attending a rheumatic diseases clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Seasonal variation in the onset of acute microcrystalline arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Effect of weather conditions on acute gouty arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout without hyperuricemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Clinical manifestations of Korean female gouty patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Crystal-associated arthropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Incidence of diabetes and gout in hypertensive patients during 8 years of follow-up. The General Practice Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Racial differences in the incidence of gout. The role of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

The management of gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout. Easy to misdiagnose

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Acute gouty arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout: can management be improved?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Risks and benefits of drugs used in the management and prevention of gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout and hyperuricemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

How is gout managed in primary care? A review of current practice and proposed guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Crystal deposition disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Effectiveness of etodolac (‘Lodine’) compared with naproxen in patients with acute gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Flurbiprofen in the treatment of acute gout. A comparison with indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Colchicine: 1998 update.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

1 reference

7 January 2021

Does colchicine work? The results of the first controlled study in acute gout.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Colchicine myopathy and neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Systemic steroid therapy for acute gout: a clinical trial and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Corticotropin for acute management of gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

How well have diagnostic tests and therapies for gout been evaluated?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Crystal-induced arthritis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Advances in management of rheumatic disease. 1965 to 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Gout and pseudogout in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980158-3

7 January 2021

10.1016/S0149-2918(03)80158-3

Identifiers

DOI

1 reference

6 August 2017

1 reference